We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B Turnover 51.11%
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+15.08%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.85B
AUM Growth
-$122M
Cap. Flow
-$553M
Cap. Flow %
-29.79%
Top 10 Hldgs %
74.46%
Holding
121
New
44
Increased
20
Reduced
8
Closed
32
Avg Time Held Equity + Options
0.3 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.3 years
Top 10 Avg Time Held Equity only
0.4 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
TECD
Tech Data Corp
TECD
+$29.6M
2
TIF
Tiffany & Co.
TIF
+$26.6M
3
LPT
Liberty Property Trust
LPT
+$17.2M
4
AGN
Allergan plc
AGN
+$16.2M
5
MDCO
Medicines Co
MDCO
+$13.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$44.7M
2
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$13.8M
3
CBM
Cambrex Corporation
CBM
+$7.14M
4
WBC
WABCO HOLDINGS INC.
WBC
+$7.02M
5
GWR
Genesee & Wyoming Inc.
GWR
+$6.91M

Sector Composition

Rank Sector Weight
1 Miscellaneous 79.37%
2 Healthcare 8.05%
3 Consumer Discretionary 2.94%
4 Technology 2.46%
5 Communication Services 2.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ACAD icon
76
PUT
Acadia Pharmaceuticals
ACAD
$3.31B
– –
-38,100
Closed -$1.37M –
AMRN icon
77
Amarin Corp
AMRN
$238M
– –
-2,500
Closed -$758K –
AVTR icon
78
PUT
Avantor
AVTR
$10.9B
– –
-10,000
Closed -$147K –
BIIB icon
79
CALL
Biogen
BIIB
$34.6B
– –
-303,400
Closed -$70.7M –
ENTX icon
80
Entera Bio
ENTX
$471M
– –
-369,000
Closed -$919K –
GOSS icon
81
CALL
Gossamer Bio
GOSS
$54.4M
– –
-1,275
Closed -$1.71M –
GOSS icon
82
PUT
Gossamer Bio
GOSS
$54.4M
– –
-3,233
Closed -$4.34M –
HHH icon
83
Howard Hughes
HHH
$4.11B
– –
-11,539
Closed -$1.43M –
ILMN icon
84
Illumina
ILMN
$39.6B
– –
-7,402
Closed -$2.19M –
SPR icon
85
DELISTED
Spirit AeroSystems
SPR
– –
-2,500
Closed -$206K –
SPY icon
86
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$807B
– –
-250,000
Closed -$74.2M –
SRPT icon
87
PUT
Sarepta Therapeutics
SRPT
$1.81B
– –
-31,500
Closed -$2.37M –
PVLA icon
88
Palvella Therapeutics
PVLA
$1.72B
– –
-313
Closed -$85K –
TVRD icon
89
PUT
Tvardi Therapeutics
TVRD
$13.3M
– –
-4,581
Closed -$3.01M –
ITCI icon
90
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-202,000
Closed -$1.51M –
AVTR.PRA icon
91
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
– –
-30,000
Closed -$1.6M –
GWPH
92
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-68,000
Closed -$7.82M –
FOMX
93
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-525,000
Closed -$1.6M –
GWR
94
DELISTED
Genesee & Wyoming Inc.
GWR
– –
-62,516
Closed -$6.91M –
PVTL
95
DELISTED
Pivotal Software, Inc.
PVTL
– –
-300,000
Closed -$4.48M –
PSDO
96
DELISTED
Presidio, Inc. Common Stock
PSDO
– –
-190,000
Closed -$3.21M –
ONCE
97
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-142,500
Closed -$13.8M –
STI icon
98
DELISTED
SunTrust Banks, Inc.
STI
– –
-3,543
Closed -$244K –
CBM
99
DELISTED
Cambrex Corporation
CBM
– –
-120,000
Closed -$7.14M –
VIAB
100
DELISTED
Viacom Inc. Class B
VIAB
– –
-257,903
Closed -$6.2M –
1 2 3
4
5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.52B AUM 3.09% 1-Year Est. Return

DLD Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, DLD Asset Management held 121 positions worth $1.85B, down 6.2% from $1.98B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

DLD Asset Management withdrew a net $553M in Q4 2019, closing 32 positions and reducing 8 holdings. Its most notable exit was Celgene Corp, an estimated $44.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 87% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, DLD Asset Management opened a new position in Tech Data Corp worth $33M.

  • DLD Asset Management's largest Q4 2019 buy was Tech Data Corp: 230,000 shares worth $33M.
  • DLD Asset Management added most to Allergan plc in Q4 2019, an estimated $16.2M increase.
  • DLD Asset Management's biggest Q4 2019 reduction was WABCO HOLDINGS INC., cutting an estimated $7.02M.
  • DLD Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $44.7M.
  • DLD Asset Management's ten largest holdings make up 74% of its $1.85B portfolio in Q4 2019.
  • DLD Asset Management opened 44 new positions and closed 32 in Q4 2019.
  • DLD Asset Management's portfolio value fell 6.2% quarter-over-quarter to $1.85B.

Based on DLD Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.